Back to search

Article

G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progression

2020-12-09

Abstract excerpt

<h4>Background: </h4> Clear cell renal cell carcinoma (ccRCC) is a cell metabolic disease with high metastasis rate and poor prognosis. Our previous studies demonstrate that glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting enzyme of the pentose phosphate pathway, is highly expressed in ccRCC and predicts poor outcomes of ccRCC patients. The aims of this study were to confirm the oncogenic role...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06b103bf-389c-5560-9d8e-32acd58c7200
DOI
10.21203/rs.3.rs-110205/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
G6PD upregulates Cyclin E1 and MMP9 to promote clear cell renal cell carcinoma progressionDOI 10.21203/rs.3.rs-110205/v1
Select a neighboring publication to make it the new centre.